Immune mechanisms of food allergy

Current Opinion in Gastroenterology

Volumn 14, Issue 6, 1998, Pages 498-503

  Teitelbaum, Jonathan E ^a   Furuta, Glenn T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

DIAGNOSTIC TEST; EOSINOPHIL; FOOD ALLERGY; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; IMMUNOCOMPETENT CELL; INTESTINE MUCOSA; MAST CELL; MUCOSAL IMMUNITY; REVIEW; T LYMPHOCYTE;

EID: 0032452435     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199811010-00014     Document Type: Review

References (29)

1. Abreu-Martin MT, Targan SR: Regulation of immune responses of the intestinal mucosa. Crit Rev Immunol 1996, 16:277-309.
2. Koning H, Baert MRM, Oranje AP, Savelkoul HFJ, Neijens HJ: Development of immune functions related to allergic mechanisms in young children. Pediatr Res 1996, 40:363-375.
3. Sampson HA: Food allergy. JAMA 1997, 278:1888-1894.
4. Bock SA: Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics 1987, 79:683-688.
5. Young E, Stoneham MD, Petruckevitch A, Barton J, Rona R: A population study of food intolerance. Lancet 1994, 343:1127-1130.
6. Wershil BK, Furuta GT, Wang Z-S, Galli SJ: Mast cell-dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology 1996, 110:1482-1490.
7. Furuta GT, Schmidt-Choudhury A, Wang MY, Wang ZS, Furlano RI, Wershil BK: Mast cell-dependent tumor necrosis factor a production participates in allergic gastric inflammation in mice. Gastroenterology 1997, 113:1560-1569. This study provides a mechanism for the IgE-, mast cell-dependent neutrophil infiltration of the stomach of mice. During this late-phase allergic response, mast cells are shown to be at least one source of TNF-α mRNA.
8. Berin MC, Kiliaan AJ, Yang PC, Groot JA, Taminiau JAJM, Perdue MH: Rapid transepithelial antigen transport in rat jejunum: impact of sensitization and the hypersensitivity reaction. Gastroenterology 1997, 133:856-864. The authors demonstrate not only the kinetics and transport abnormalities associated with allergic inflammation of the small intestine, but they also show that the process of sensitization alters intestinal permeability.
9. Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Miyajima I, Kinet JP, Galli SJ: IgE enhances mouse mast cell FcεRI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997, 185:663-672. IgE-dependent reactions occur through the crosslinking of IgE molecules on the surface of mast cells and basophils with specific antigen. The authors now show that increased concentrations of IgE also upregulates FcεRI expression and increases inflammatory responses.
10. Lantz CS, Yamaguchi M, Oetlgen HC, Katona IM, Miyajima I, Kinet JP, Galli SJ: IgE regulates mouse basophil FcεRI expression in vivo. J Immunol 1997, 158:2517-21.
11. Prodeus AP, Zhou X, Maurer M, Galli SJ, Carroll MC: Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 1997, 390:172-75. Although IgE immunoglobulins are known as the traditional activators of mast cells, they are not the only such molecules capable of stimulating mast cell responses. This study shows that complement is critical to the mast cell-dependent clearance of bacterial peritonitis and, importantly, demonstrate a protective effect of mast cells.
12. Furuta GT, Wang ZS, Wershil BK: Gastric inflammation during systemic anaphylaxis: neutrophil recruitment in the stomach wall of mice does not require mast cell participation. Dig Dis Sci 1998, 43:2021-2027.
13. 1 lymphocyte profile. These findings again show that the tests of the systemic immune condition do not always correlate with those found in the intestinal mucosa.
14. Wallaert B, Desreumaux P, Copin MC, Tillie I, Benard A, Colombel JF, Gosselin B, Tonnel AB, Janin A: Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med 1995, 182:1897-1904.
15. Knutson TW, Bengtsson U, Dannaeus A, Ahlstedt S, Knutson L: Effects of luminal antigen on intestinal albumin and hyaluronan permeability and ion transport in atopic patients. J Allergy Clin Immunol 1996, 97:1225-1232.
16. Benard A, Desreumeaux P, Huglo D, Hoorelbeke A, Tonnel AB, Wallaert B: Increased intestinal permeability in bronchial asthma. J Allergy Clin Immunol 1996, 97:1173-1178.
17. Tariq SM, Matthews SM, Hakim EA, Stevens M, Arshad SH, Hide DW: The prevalence of and risk factors for atopy in early childhood: a whole population birth cohort study. J Allergy Clin Immunol 1998, 101:587-593.
18. Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CIM, Meyers DA, Levitt RC: Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995, 333:894-900. This important finding demonstrates that atopic asthmatics may have a genetic predisposition. Because this phenotype is related to the overproduction of IgE, therapeutic options may be expanded to affect the production or attachment of IgE molecules. Although these specific types of treatments have not yet been attempted in gastrointestinal allergic disease, their use may arrive as more is understood about the pathophysiology and genetics of gastrointestinal atopic diseases.
19. Hershey GKK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA: The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor. N Engl J Med 1997, 337:1720-1725. The investigators determine another important genetic mutation associated with the atopic state. Their findings suggest that allergic conditions may arise from the over expression of the effects of IL-4. Whether this finding, as well as the previous mutations identified, are related to gastrointestinal allergic disorders remains to be proven.
20. Ryan JJ: Interleukin-4 and its receptor: essential mediators of the allergic response. J Allergy Clin Immunol 1997, 99:1-5.
21. Hoffman KM, Ho DG, Sampson HA: Evaluation of the usefulness of lymphocyte proliferation assays in the diagnosis of allergy to cow's milk. J Allergy Clin Immunol 1997, 99:360-366.
22. Bengtsson U, Nilsson-Balknas U, Hanson La, Ahlstedt S: Double blind, placebo controlled food reactions do not correlate to IgE allergy in the diagnosis of staple food related gastrointestinal symptoms. Gut 1996, 39:130-135.
23. Sampson HA, Ho DG: Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol 1997, 100:444-451. Patients with very high levels of food-specific IgE antibodies are likely (>95%) to have a clinical allergic reaction to that food antigen.
24. Bischoff SC, Mayer J, Wademeyer J, Meier PN, Zeck-Kapp G, Wedi B, Kapp A, Cetin Y, Gebel M, Manns MP: Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergy. Gut 1997, 40:745-753. Seventy adult patients with suspected food allergy had intracecal challenge with food antigens. A wheal and flare reaction was seen in 77% of index patients and none of the control subjects. There was no significant relationship between skin test and colonoscopic allergen provocation test results to the same antigen. Histologically there was mast cell and eosinophil degranulation. Although skin testing and serum immune testing prove to be nonspecific in the screening of patients for food allergy, colonoscopic allergen provocation testing provides clinicians with a means of eliciting antigen-specific gastrointestinal reactions to various food proteins.
25. Bengtsson U, Knutson TW, Knutson L, Dannaues A, Haligren R, Ahlstedt S: Eosinophil cationic protein and histamine after intestinal challenge in patients with cow's milk intolerance. J Allergy Clin Immunol 1997, 100:216-221.
26. Bischoff SC, Grabowsky J, Mannis MP: Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci 1997, 42:394-403.
27. Majamaa H, Miettinen A, Laine S, Isolauri E: Intestinal inflammation in children with atopic eczema: faecal eosinophil cationic protein and tumor necrosis factor-α as non-invasive indicators of food allergy. Clin Exp Allergy 1996, 26:181-187.
28. Vanderhoof JA, Murray ND, Kaufman SS, Mack DR, Antonson DL, Corkins MR, Perry D, Kruger R: Intolerance to protein hydrolysate infant formulas: an underrecognized cause of gastrointestinal symptoms in infants. J Pediatr 1997, 131:741-744. Infants with milk protein allergy and persistence of symptoms on protein hydrolysate formula had resolution of those symptoms with an ammo acid - based formula.
29. de Boissieu D, Matarazzo P, Dupont C: Allergy to extensively hydrolyzed cow milk proteins in infants: identification and treatment with an amino acid-based formula. J Pediatr 1997, 131:744-747.